Glutamate, Immune Cells and Alzheimer’s Disease: An Attempt to Link the Triad
Open Access
- 28 July 2026
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 46 (1)
Abstract
Glutamate (Glu), although the main excitatory neurotransmitter (NT) of the central nervous system (CNS), evidence recognizes its role in influencing immune cell function and activation, including cytokine production, cell proliferation, migration, and survival. Importantly, dysregulation of Glu homeostasis has been implicated in the pathogenesis of Alzheimer’s disease (AD), a neurodegenerative disorder characterized by progressive cognitive decline, neuronal loss and neuroinflammation. This review synthesizes current evidence on the biochemistry of the glutamatergic synapse, as well as the expression and signaling of Glu receptors (GluRs) in human immune cells. Furthermore, it examines two major hypotheses of AD pathogenesis —the glutamatergic and the neuroimmune hypothesis— and proposes a unified glutamatergic–neuroimmune framework. In this model, disrupted glutamatergic signaling at the neuron–glia–immune interface may represent a central contributor to AD pathology. Understanding the glutamatergic–neuroimmune axis may provide novel insights into therapeutic strategies targeting neuroimmune modulation in AD.Keywords
Funding Information
- University of Athens
This publication has 129 references indexed in Scilit:
- Neutrophil inflammation metrics are associated with the risk of future dementia in large‐scale electronic health record data from hospital systemsAlzheimer's & Dementia, 2025
- Neurotransmitters and Immunity: Molecular Mechanisms, Biological Functions, Diseases, and Potential Therapeutic TargetsMedcomm, 2025
- The interaction of innate immune and adaptive immune systemMedcomm, 2024
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- Metabotropic Glutamate Receptor 5 in Natural Killer Cells Attenuates Liver Fibrosis by Exerting Cytotoxicity to Activated Stellate CellsHepatology, 2021
- Allocation of National Institutes of Health Funding by Disease Category in 2008 and 2019JAMA Network Open, 2021
- The “quad‐partite” synapse: Microglia‐synapse interactions in the developing and mature CNSGlia, 2012
- The glutamate‐glutamine cycle is not stoichiometric: Fates of glutamate in brainJournal of Neuroscience Research, 2007
- Reduced expression of metabotropic glutamate receptor 2mRNA in T cells of ALS patientsAnnals of Neurology, 2005
- The Discovery of Chemical NeurotransmittersBrain and Cognition, 2002